Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems-Reference-Cited by-同舟云学术

Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems

Published:2013-11-01 Issue:5 Volume:27 Page:681-689
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Fu Bin,Jaso Jesse M,Sargent Rachel L,Goswami Maitrayee,Verstovsek Srdan,Medeiros L Jeffrey,Wang Sa A

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2013187.pdf

Reference28 articles.

1. Verhoef GE, De Wolf-Peeters C, Ferrant A et al. Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann Hematol 1991;63:235–241.

2. Lambertenghi-Deliliers G, Orazi A, Luksch R et al. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol 1991;78:161–166.

3. Vardiman JW, Thiele J, Arber DA et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937–951.

4. Buesche G, Teoman H, Wilczak W et al. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. Leukemia 2008;22:313–322.

5. Della Porta MG, Malcovati L, Boveri E et al. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. J Clin Oncol 2009;27:754–762.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid sarcoma in JAK2-positive myelodysplastic neoplasms with fibrosis: a case report and literature review;Journal of International Medical Research;2024-08

2. A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC;Journal of Hematology & Oncology;2024-07-29

3. GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromes;2024-06-12

4. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms;Blood Cancer Journal;2024-04-09

5. Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation;Journal of Translational Medicine;2024-03-13